Featured Research

from universities, journals, and other organizations

Malnourished children still have hope beyond first 1,000 days

Date:
December 11, 2013
Source:
Brigham Young University
Summary:
New research is finding that global health workers should not give up on impoverished children after the first 1,000 days. In a longitudinal study of 8,000 children from four poverty-laden countries, health science researchers found that the developmental damage of malnutrition during the first 1,000 days is not irreversible.

Three children in Cambodia eating a meal.
Credit: Brigham Young University

Children who are malnourished during their first 1,000 days (conception to age 2) often experience developmental setbacks that affect them for life.

To that end, philanthropic groups have funded massive global health initiatives for impoverished infants and pregnant women around the world. While money flows justifiably to this cause, programs for children past the 1,000-day mark are seen as having little hope, and garner less support.

But new research from Brigham Young University is finding that global health workers should not give up on impoverished children after that critical time frame.

In a longitudinal study of 8,000 children from four poverty-laden countries, BYU health science assistant professor Ben Crookston and colleagues found that the developmental damage of malnutrition during the first 1,000 days is not irreversible.

"The first 1,000 days are extremely critical, but we found that the programs aimed at helping children after those first two years are still impactful," Crookston said.

Specifically, the study found that nutritional recovery after early growth faltering might have significant benefits on schooling and cognitive achievement.

The data for the study, which comes from the international "Young Lives" project led by the University of Oxford, tracked the first eight years of life of children from Ethiopia, Peru, India and Vietnam.

Initially, Crookston and his colleagues found what they expected with the data: Children who had stunted growth (in this case, shorter than expected height at 1 year of age) ended up behind in school and scoring lower on cognitive tests at 8 years of age.

However, kids who experienced "catch-up growth," scored relatively better on tests than those who continued to grow slowly and were in more age-appropriate classes by the age of 8.

Yale professor Rafael Perez-Escamilla, the director of the Office of Public Health Practice at the Yale School of Public Health, called the study "well-designed" and "robust" in an editorial accompanying the research published in the December issue of the American Journal of Clinical Nutrition.

"The findings from Crookston are in general agreement with previous empirical evidence suggesting the brain is a highly plastic organ with remarkable ability to improve its function, even when interventions start after exposure to nutritional insults during the first 1,000 days of life," Perez-Escamilla wrote.

BYU's Crookston said he hopes the study informs better policy and practice so that programs such as preschool lunch (which improves nutrition for preprimary and primary school age children) receive continued support.

"The first 1,000 days is the most critical window, but nutrition should still be a life focus," he said. "We shouldn't give up on those kids and we should continue programs because we can still have modest, but meaningful returns."


Story Source:

The above story is based on materials provided by Brigham Young University. Note: Materials may be edited for content and length.


Journal Reference:

  1. B. T. Crookston, W. Schott, S. Cueto, K. A. Dearden, P. Engle, A. Georgiadis, E. A. Lundeen, M. E. Penny, A. D. Stein, J. R. Behrman. Postinfancy growth, schooling, and cognitive achievement: Young Lives. American Journal of Clinical Nutrition, 2013; 98 (6): 1555 DOI: 10.3945/%u200Bajcn.113.067561

Cite This Page:

Brigham Young University. "Malnourished children still have hope beyond first 1,000 days." ScienceDaily. ScienceDaily, 11 December 2013. <www.sciencedaily.com/releases/2013/12/131211132724.htm>.
Brigham Young University. (2013, December 11). Malnourished children still have hope beyond first 1,000 days. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/12/131211132724.htm
Brigham Young University. "Malnourished children still have hope beyond first 1,000 days." ScienceDaily. www.sciencedaily.com/releases/2013/12/131211132724.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins